Deka Research and Development: FDA filings under this applicant name

FDA lists 29 510(k) clearances under 5 spellings of the applicant name “Deka Research and Development” (first 1984, latest 2026), across 11 product codes in 4 review panels. Median 510(k) review time under this name: 99 days. Since 2017 the median was 94 days, against 202 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

510(k) clearances per year

YearClearancesMedian review days
20120—
20131169
20140—
20151123
20161278
20170—
20181184
2019194
20202194
20210—
20220—
20231627
2024989
20254122
2026327

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Deka Research and Development took a median 94 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 202 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
LDRController, Infusion, Intravascular, Electronic55
QFGAlternate Controller Enabled Insulin Infusion Pump55
QJYInfusion Pump, Drug Specific, Pharmacy-Filled44
FKXSystem, Peritoneal, Automatic Delivery33
FPASet, Administration, Intravascular33
FRNPump, Infusion33
QJIInteroperable Automated Glycemic Controller22
FIGClamp, Tubing, Blood, Automatic11
IMKWheelchair, Stair Climbing11
KDIDialyzer, High Permeability With Or Without Sealed Dialysate System11

Plus 1 more product codes.

Review panels

Most recent Deka Research and Development 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K262576twiist Loop AlgorithmQJI2026-10-1580
K261672twiist Automated Insulin Delivery (AID) SystemQFG2026-06-1727
K261530iiSure Infusion SetFPA2026-06-0326
K243841Sparta Infusion Set for InsulinFPA2025-08-01231
K250930twiist systemQFG2025-04-025
K250357RemunityPRO™ Pump for Remodulin® (treprostinil) InjectionFRN2025-03-1132
K241736Remunity 2.0 Pump for Remodulin (treprostinil) InjectionFRN2025-01-16213
K243354Remunity SystemQJY2024-11-2729
K242693DEKA Infusion System, DEKA Administration SetLDR2024-10-0728
K240920HemoCare Bicarbonate Concentrate Set (BCS)KPO2024-07-1299

19 earlier clearances. See the full list in Caduvo.

Recalls

FDA recall records list no recalls under a recalling firm named Deka Research and Development.

9 product recalls in 7 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 1 initiated in the last five years. Most often: Baxter Healthcare Corporation (4), BAXTER HEALTHCARE CORPORATION (2), Baxter Healthcare Corp. (2).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Device clinical trials

An industry sponsor named Deka Research and Development is the lead sponsor of 4 device studies on ClinicalTrials.gov (1 active or recruiting). Most recent:

Related HCPCS codes

HCPCS Level II codes whose descriptors match the device names of the product codes filed under Deka Research and Development (a text match, not an official crosswalk):

FDA spellings included

FDA records this applicant under 5 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Deka Research and Development?

FDA lists 29 510(k) clearances under 5 spellings of the applicant name “Deka Research and Development” (first 1984, latest 2026), across 11 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Deka Research and Development?

The median time from FDA receipt to decision across 510(k)s cleared under the name Deka Research and Development is 99 days. Since 2017: 94 days, versus 202 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Deka Research and Development?

The most frequent FDA product codes under this applicant name are LDR (Controller, Infusion, Intravascular, Electronic, 5); QFG (Alternate Controller Enabled Insulin Infusion Pump, 5); QJY (Infusion Pump, Drug Specific, Pharmacy-Filled, 4).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup